AlphaStar Capital Management, LLC - SPDR SER TR ownership

SPDR SER TR's ticker is SPTL and the CUSIP is 78464A664. A total of 217 filers reported holding SPDR SER TR in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
AlphaStar Capital Management, LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2022$2,102,000
-32.5%
70,917
-24.7%
0.23%
-21.5%
Q2 2022$3,112,000
-64.4%
94,118
-59.2%
0.29%
-59.1%
Q1 2022$8,732,000
-23.7%
230,891
-18.3%
0.70%
-22.7%
Q4 2021$11,441,000
-15.1%
282,505
-14.3%
0.91%
-0.7%
Q3 2021$13,471,000
+47.9%
329,521
+49.4%
0.92%
-21.3%
Q2 2021$9,109,000
+6.5%
220,569
+0.5%
1.17%
-12.2%
Q1 2021$8,555,000
-9.5%
219,470
+0.9%
1.33%
-17.2%
Q4 2020$9,458,000
+7.9%
217,435
+14.1%
1.60%
-8.5%
Q3 2020$8,768,000
+32.9%
190,521
+37.4%
1.75%
+24.4%
Q2 2020$6,599,000
+46.8%
138,663
+50.7%
1.41%
+33.1%
Q1 2020$4,495,000
-7.1%
92,017
-26.1%
1.06%
+0.9%
Q4 2019$4,839,000
+57.8%
124,487
+66.6%
1.05%
+43.6%
Q3 2019$3,066,000
-4.4%
74,722
-11.1%
0.73%
-9.9%
Q2 2019$3,208,000
+273.9%
84,077
+256.5%
0.81%
+237.9%
Q1 2019$858,000
+6.7%
23,581
+2.8%
0.24%
-6.6%
Q4 2018$804,000
-17.3%
22,946
-20.2%
0.26%
-10.1%
Q3 2018$972,000
-10.6%
28,751
-7.3%
0.29%
-16.6%
Q2 2018$1,087,000
-24.5%
31,022
-24.4%
0.34%
-37.3%
Q1 2018$1,440,000
+143900.0%
41,017
+163968.0%
0.55%
+348.4%
Q2 2017$1,000250.12%
Other shareholders
SPDR SER TR shareholders Q3 2021
NameSharesValueWeighting ↓
Strategic Wealth Investment Group, LLC 1,411,264$59,485,00015.47%
Frontier Asset Management, LLC 354,755$14,953,00011.02%
SHEPHERD KAPLAN KROCHUK, LLC 619,260$26,102,0009.40%
AllGen Financial Advisors, Inc. 259,892$10,954,4368.12%
Nan Shan Life Insurance Co., Ltd. 9,256,900$390,178,0005.92%
O'Brien Wealth Partners LLC 402,098$15,855,0005.50%
Intelligence Driven Advisers, LLC 678,987$27,506,0005.05%
ISLAY CAPITAL MANAGEMENT, LLC 149,369$6,296,0004.76%
Tradewinds Capital Management, LLC 529,194$22,306,0003.42%
S. R. Schill & Associates 161,290$6,798,0002.71%
View complete list of SPDR SER TR shareholders